“Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab”. The Review of Diabetic Studies (April 18, 2025): 120–130. Accessed October 29, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/656.